SEC Form 4 · accession 0001179110-17-008651
Editas Medicine, Inc. · EDIT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Boris Nikolic
Director
Period of report
Jun 2, 2017
Accepted (ET)
Jun 6, 2017 · 4:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001650664
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 2, 2017 | P | 35,000 | $14.0722 | A | 35,000 | D | |
| Common StockF2 | holding | — | — | — | 2,649,572 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.9 per share to $14.15 per share, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- F2These shares are owned by bng0, LLC. Boris Nikolic, as a member and the managing director of bng0, LLC, has voting and investment power over such shares and may be deemed the indirect beneficial owner of such shares. Boris Nikolic disclaims beneficial ownership over such shares, except to the extent of any pecuniary interest therein.